KMS Medisurgi Ltd
₹ 125
2.53%
05 Apr 2024
About
Incorporated in 2016, KMS Medisurgi Ltd manufactures and sells Surgical Equipment[1]
Key Points
- Market Cap ₹ 41.2 Cr.
- Current Price ₹ 125
- High / Low ₹ 125 / 125
- Stock P/E
- Book Value ₹ 23.4
- Dividend Yield 0.04 %
- ROCE 8.40 %
- ROE 6.58 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 200 to 152 days.
Cons
- Stock is trading at 5.34 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of 6.11% over last 3 years.
- Company has high debtors of 152 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6.15 | 7.62 | 8.89 | 8.41 | 7.90 | 7.32 | 9.86 | 10.34 | 7.51 | 10.32 | 11.03 | 13.88 | 14.54 | |
5.91 | 7.01 | 8.17 | 7.59 | 6.95 | 6.85 | 9.56 | 9.68 | 7.01 | 9.79 | 10.07 | 13.03 | 14.44 | |
Operating Profit | 0.24 | 0.61 | 0.72 | 0.82 | 0.95 | 0.47 | 0.30 | 0.66 | 0.50 | 0.53 | 0.96 | 0.85 | 0.10 |
OPM % | 3.90% | 8.01% | 8.10% | 9.75% | 12.03% | 6.42% | 3.04% | 6.38% | 6.66% | 5.14% | 8.70% | 6.12% | 0.69% |
0.07 | 0.05 | 0.04 | 0.06 | 0.17 | 0.35 | 0.42 | 0.00 | 0.10 | 0.05 | 0.02 | 0.03 | 0.05 | |
Interest | 0.09 | 0.23 | 0.27 | 0.24 | 0.27 | 0.19 | 0.09 | 0.07 | 0.03 | 0.00 | 0.00 | 0.02 | 0.03 |
Depreciation | 0.13 | 0.39 | 0.41 | 0.34 | 0.49 | 0.45 | 0.43 | 0.41 | 0.33 | 0.29 | 0.32 | 0.25 | 0.25 |
Profit before tax | 0.09 | 0.04 | 0.08 | 0.30 | 0.36 | 0.18 | 0.20 | 0.18 | 0.24 | 0.29 | 0.66 | 0.61 | -0.13 |
Tax % | 33.33% | 50.00% | 50.00% | 53.33% | 38.89% | 50.00% | 40.00% | 38.89% | 45.83% | 24.14% | 13.64% | 24.59% | |
0.05 | 0.03 | 0.03 | 0.14 | 0.21 | 0.10 | 0.12 | 0.11 | 0.12 | 0.22 | 0.57 | 0.45 | -0.07 | |
EPS in Rs | 1.00 | 0.60 | 0.60 | 1.17 | 0.88 | 0.30 | 0.36 | 0.33 | 0.36 | 0.67 | 1.73 | 1.36 | -0.21 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 25.71% | 5.71% | 16.50% | 13.75% | 15.00% | 13.75% | 7.50% | 2.89% | 3.67% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 7% |
3 Years: | 23% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | 32% |
5 Years: | 33% |
3 Years: | 60% |
TTM: | -108% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 54% |
1 Year: | 3% |
Return on Equity | |
---|---|
10 Years: | 4% |
5 Years: | 4% |
3 Years: | 6% |
Last Year: | 7% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.50 | 0.50 | 0.50 | 1.20 | 2.40 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 |
Reserves | 0.58 | 0.61 | 0.64 | 2.13 | 1.12 | 2.85 | 2.95 | 3.05 | 3.15 | 3.37 | 3.93 | 4.36 | 4.42 |
2.42 | 3.99 | 2.85 | 2.13 | 2.73 | 1.91 | 1.13 | 1.11 | 1.03 | 0.99 | 0.99 | 0.54 | 0.85 | |
1.11 | 1.91 | 3.21 | 2.60 | 2.36 | 2.14 | 3.15 | 1.64 | 1.86 | 2.17 | 1.51 | 2.65 | 3.68 | |
Total Liabilities | 4.61 | 7.01 | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 12.25 |
1.28 | 2.72 | 2.25 | 1.98 | 2.69 | 2.25 | 2.20 | 1.81 | 1.65 | 1.48 | 1.82 | 1.65 | 1.67 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
3.33 | 4.29 | 4.95 | 6.08 | 5.92 | 7.95 | 8.33 | 7.29 | 7.69 | 8.35 | 7.91 | 9.20 | 10.58 | |
Total Assets | 4.61 | 7.01 | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 12.25 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.06 | 0.02 | 1.35 | -0.24 | 0.90 | -1.57 | 0.75 | -0.84 | 0.53 | -0.07 | 0.46 | 1.21 | |
-0.87 | -1.82 | 0.05 | -0.03 | -1.10 | 0.11 | -0.31 | 0.01 | -0.10 | -0.12 | -0.66 | -0.52 | |
0.74 | 1.87 | -1.41 | 1.13 | 1.75 | 1.57 | -0.81 | -0.06 | -0.11 | -0.02 | -0.01 | -0.46 | |
Net Cash Flow | -0.07 | 0.06 | -0.01 | 0.86 | 1.56 | 0.10 | -0.37 | -0.88 | 0.32 | -0.21 | -0.21 | 0.23 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 124.04 | 143.22 | 128.10 | 163.19 | 185.73 | 233.36 | 186.94 | 194.15 | 305.22 | 231.31 | 216.42 | 152.00 |
Inventory Days | 9.38 | 23.34 | 50.02 | 17.78 | 6.24 | 85.34 | 82.27 | 62.14 | 45.45 | 42.45 | 70.96 | |
Days Payable | 77.38 | 110.10 | 155.51 | 141.02 | 139.76 | 134.58 | 134.09 | 70.42 | 100.27 | 58.60 | 85.22 | |
Cash Conversion Cycle | 56.04 | 56.46 | 22.61 | 39.94 | 52.21 | 184.13 | 135.12 | 185.86 | 305.22 | 176.49 | 200.27 | 137.74 |
Working Capital Days | 78.34 | 93.41 | 54.20 | 95.05 | 97.95 | 212.92 | 148.07 | 188.85 | 253.22 | 200.54 | 199.54 | 153.84 |
ROCE % | 5.64% | 6.28% | 7.70% | 11.43% | 10.76% | 5.17% | 3.76% | 3.37% | 3.61% | 3.83% | 8.31% | 8.40% |
Documents
Announcements
-
Non-Applicability Of Disclosure Of Related Party Transactions
14 Nov - Non-applicability of related party transactions disclosure.
- Submission Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 14 Nov
-
Board Meeting Outcome for Submission Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
14 Nov - Submission of unaudited financial results for Q2 2024.
-
Board Meeting Intimation for Board Meeting Intimation
12 Nov - Board meeting on November 14 to approve financial results.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 10 Oct
Business Overview:[1]
Company manufactures and undertakes jobwork of coating of various substrates films, cotton fabrics, taffeta silk fabrics with adhesive. It is in the business of marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipment, Surgery equipment, Orthopaedic/ Physiotherapy equipment, Blood Banking Equipment, etc.